Twin Peaks Wealth Advisors’s Terns Pharmaceuticals TERN Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4	Closed	-$211	–	1988
2026 Q1	$211	Buy	+4	New	+$164	﹤0.01%	2164

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Twin Peaks Wealth Advisors's TERN Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 4 shares — an estimated $211 sold.

Twin Peaks Wealth Advisors first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $211 in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Twin Peaks Wealth Advisors reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Twin Peaks Wealth Advisors sold 4 Terns Pharmaceuticals shares in Q2 2026, an estimated $211.
Twin Peaks Wealth Advisors first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Twin Peaks Wealth Advisors's Terns Pharmaceuticals position peaked at $211 in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.